Jianguang Lu
Department Of Peptide Drugs R&D
Shanghai, China
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Discovery of TL10: A Soluble and Long-Acting MC4R Agonist with Tunable Lipidation for Sustained Pharmacological Activity.
Journal: Journal of medicinal chemistry
Published: May 06, 2026
High-yield soluble expression and affinity-tag-free purification of growth hormone receptor antagonist B2036 in Escherichia coli.
Journal: Bioprocess and biosystems engineering
Published: April 28, 2026
Development and Validation of a Mechanism-Based Ba/F3-hGHR Bioassay for the Potency Assessment of Recombinant Human Growth Hormone.
Journal: Analytical biochemistry
Published: April 26, 2026
An integrated bioprocess for the production of insulin icodec in Pichia pastoris.
Journal: Preparative biochemistry & biotechnology
Published: March 18, 2026
Design, synthesis and evaluation of trofinetide prodrug based on diketopiperazine strategy.
Journal: Bioorganic & medicinal chemistry
Published: November 18, 2025
Design and synthesis of novel thrombopoietin mimetic peptides via dual-mechanistic modification.
Journal: Bioorganic & medicinal chemistry
Published: June 28, 2025
Design, Synthesis, and Biological Evaluation of a Novel Long-Acting Human Complement C3 Inhibitor Synthesized via the PASylation-Lipidation Modular (PLM) Platform.
Journal: Bioconjugate chemistry
Published: May 13, 2025
Rational Design of Site-Specific Fatty Acid Derivatives to Extend the Half-Life of Fibroblast Growth Factor 21.
Journal: Bioconjugate chemistry
Published: March 14, 2025
Novel bifunctional antibacterial peptides mediated by a covalent conjugation strategy combat priority multidrug-resistant gram-negative pathogens through dual targets.
Journal: The Journal of antibiotics
Published: March 04, 2025
Design, synthesis, and biological evaluation of long-acting glucagon-like peptide-1 (GLP-1) conjugates modified with dual fatty acids and a proline-alanine-serine (PAS) polypeptide.
Journal: Bioorganic & medicinal chemistry
Published: March 02, 2025
Lipidation-dimerization platform unlocks treatment potential of fibroblast growth factor 21 for non-alcoholic steatohepatitis.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: September 20, 2024
Last Updated: 09/26/2026